Featured Research

from universities, journals, and other organizations

Global Health Organizations Are Doing Too Little To Support Health System Strengthening

Date:
April 27, 2009
Source:
Public Library of Science
Summary:
Existing health systems in the developing world are fragile and many are unable to provide effective health services -- and so there is growing consensus that the success of global health initiatives will depend on "health system strengthening" (a recent buzzword in global health).

Existing health systems in the developing world are fragile and many are unable to provide effective health services — and so there is growing consensus that the success of global health initiatives will depend on "health system strengthening" (a recent buzzword in global health).

But a new literature review in this week's PLoS Medicine suggests that while many global health initiatives and agencies claim to support health system strengthening, their claims may not always be matched by their actions.

Bruno Marchal and colleagues at the Institute of Tropical Medicine-Antwerp, Belgium, reviewed the key strategic documents published by major global health initiatives and agencies (the authors use the term "global health actors"). Some examples of global health actors included in their review are UNAIDS; WHO; the Global Fund to Fight AIDS, Tuberculosis and Malaria; Roll Back Malaria; the African Programme for Onchocerciasis Control; the Global Alliance for Vaccines and Immunization; and the Global Network for Neglected Tropical Disease Control.

Marchal and colleagues examined the claims that these global health actors made about the importance of health system strengthening and compared these with the actors' actual activities and programmes.

"We found a clear gap between the language used by global health actors and their actual activities," say Marchal and colleagues. "Virtually all global health actors claim to support health systems, but instead they focus on disease-specific interventions or on activities targeting health system functions essential for implementation of their own programmes."

The authors argue that global health actors tend to emphasize, in their strategic documents, the importance of interventions that can achieve a rapid impact and that have measurable short-term outcomes — rather than the longer-term goal of health system strengthening.

When these global health actors do address weak health systems, they often do so in a way that selectively helps their own programme achieve its goals. "In practice," they say, "micro-level solutions (incentives and support for general health services carrying out programme activities) or support to specific sub-systems essential for effectively implementing the programme (drug delivery, surveillance, etc.) are the norm."

Although global health actors identify weak health systems as the major barrier to the success of their programmes, say Marchal and colleagues, their responses tend to focus on their own specific objectives.

This literature review was funded by institutional funding of the Institute of Tropical Medicine, Antwerp. The funders had no role in designing, conducting, or analyzing the literature review, the decision to publish, or preparation of the manuscript.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Marchal B, Cavalli A, Kegels G. Global Health Actors Claim To Support Health System Strengthening%u2014Is This Reality or Rhetoric? PLoS Med, 6(4): e1000059 DOI: 10.1371/journal.pmed.1000059

Cite This Page:

Public Library of Science. "Global Health Organizations Are Doing Too Little To Support Health System Strengthening." ScienceDaily. ScienceDaily, 27 April 2009. <www.sciencedaily.com/releases/2009/04/090427203650.htm>.
Public Library of Science. (2009, April 27). Global Health Organizations Are Doing Too Little To Support Health System Strengthening. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/04/090427203650.htm
Public Library of Science. "Global Health Organizations Are Doing Too Little To Support Health System Strengthening." ScienceDaily. www.sciencedaily.com/releases/2009/04/090427203650.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins